Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 215

1.

Is depot medication safe in the setting of myopathy?

Price JR, Bastiampillai T, Dhillon RS.

Aust N Z J Psychiatry. 2009 Aug;43(8):781-3. doi: 10.1080/00048670903002008. No abstract available.

PMID:
19629801
[PubMed - indexed for MEDLINE]
2.

Applying long-acting injectable antipsychotics in first-episode schizophrenia to achieve first remission.

Liu CC, Chiang HL, Wu SY.

CNS Drugs. 2008;22(3):257-8. No abstract available.

PMID:
18278979
[PubMed - indexed for MEDLINE]
3.

Leukopenia during therapy with risperidone long-acting injectable: two case reports.

Uzun S, Kozumplik O, Jakovljević M, Folnegović-Smalc V.

J Clin Psychopharmacol. 2008 Dec;28(6):713-4. doi: 10.1097/JCP.0b013e31818b53a1. No abstract available.

PMID:
19011449
[PubMed - indexed for MEDLINE]
4.

Hyperprolactinaemia on depot risperidone treated with aripiprazole.

Anandarajan T, Tibrewal P, Dhillon R, Bastiampillai T.

Aust N Z J Psychiatry. 2012 Aug;46(8):792-3. doi: 10.1177/0004867412445171. Epub 2012 Apr 23. No abstract available.

PMID:
22528973
[PubMed - indexed for MEDLINE]
5.

Clinical guidelines: Dosing and switching strategies for long-acting risperidone.

Marder SR, Conley R, Ereshefsky L, Kane JM, Turner MS.

J Clin Psychiatry. 2003;64 Suppl 16:41-6. No abstract available.

PMID:
14680418
[PubMed - indexed for MEDLINE]
6.

Allergic reaction to depot risperidone but not to oral risperidone.

Reeves RR, Mack JE.

J Clin Psychiatry. 2005 Jul;66(7):949. No abstract available.

PMID:
16013916
[PubMed - indexed for MEDLINE]
7.

Optimizing treatment with risperidone long-acting injections.

Ceskova E.

Acta Psychiatr Scand. 2012 Dec;126(6):479-80. doi: 10.1111/acps.12014. Epub 2012 Oct 26. No abstract available.

PMID:
23106600
[PubMed - indexed for MEDLINE]
8.

Predictors for starting depot administration of risperidone in chronic users of antipsychotics.

Vehof J, Postma MJ, Bruggeman R, De Jong-Van Den Berg LT, Van Den Berg PB, Stolk RP, Burger H.

J Clin Psychopharmacol. 2008 Dec;28(6):625-30. doi: 10.1097/JCP.0b013e31818a6d10.

PMID:
19011430
[PubMed - indexed for MEDLINE]
9.

Facialis palsy attributable to depot antipsychotic therapy.

Licina M, Tavcar R.

Can J Psychiatry. 2003 Nov;48(10):712-3. No abstract available.

PMID:
14674060
[PubMed - indexed for MEDLINE]
10.

Serum concentrations of risperidone and 9-OH risperidone following intramuscular injection of long-acting risperidone compared with oral risperidone medication.

Nesvåg R, Hendset M, Refsum H, Tanum L.

Acta Psychiatr Scand. 2006 Jul;114(1):21-6.

PMID:
16774657
[PubMed - indexed for MEDLINE]
11.

Injection site pain with long-acting risperidone.

Pinninti NR, Mago R.

J Clin Psychiatry. 2005 May;66(5):656-7; author reply, 657. No abstract available.

PMID:
15889958
[PubMed - indexed for MEDLINE]
12.

Injection of depot antipsychotic medications in patients with schizophrenia.

Fleishman M.

J Clin Psychiatry. 2002 Sep;63(9):840-1; author reply 841-2. No abstract available.

PMID:
12363128
[PubMed - indexed for MEDLINE]
13.

Inconsistency in risperidone long-acting injection steady-state plasma levels when switching from deltoid to gluteal administration.

Elliott ES, Purvis TL, Nelson LA, Sommi RW.

J Clin Pharmacol. 2010 Jun;50(6):721-4. doi: 10.1177/0091270009350622. Epub 2010 Jan 12. No abstract available.

PMID:
20067943
[PubMed - indexed for MEDLINE]
14.

Pharmacokinetics and efficacy of a direct switch from conventional depot to risperidone long-acting injection in Chinese patients with schizophrenic and schizoaffective disorders.

Lai YC, Huang MC, Chen CH, Tsai CJ, Pan CH, Chiu CC.

Psychiatry Clin Neurosci. 2009 Aug;63(4):440-8. doi: 10.1111/j.1440-1819.2009.01977.x. Epub 2009 Apr 27.

PMID:
19457210
[PubMed - indexed for MEDLINE]
15.

Risperidone vs. placebo for schizophrenia.

Kripke C.

Am Fam Physician. 2010 May 1;81(9):1096. No abstract available.

PMID:
20433125
[PubMed - indexed for MEDLINE]
Free Article
16.

An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia.

Dursun S.

J Psychopharmacol. 2005 Sep;19(5 Suppl):3-4. No abstract available.

PMID:
16144780
[PubMed - indexed for MEDLINE]
17.

Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Int Clin Psychopharmacol. 2008 Nov;23(6):325-31. doi: 10.1097/YIC.0b013e32830c2042.

PMID:
18854720
[PubMed - indexed for MEDLINE]
18.

Initial dosing strategies for long-acting injectable risperidone.

Viner MW, Matuszak JM, Knight LJ.

J Clin Psychiatry. 2006 Aug;67(8):1310-1. No abstract available.

PMID:
16965217
[PubMed - indexed for MEDLINE]
19.

Long-acting risperidone-induced periorbital edema.

Pelizza L.

J Clin Psychopharmacol. 2008 Dec;28(6):709-10. doi: 10.1097/JCP.0b013e31818ce380. No abstract available.

PMID:
19011446
[PubMed - indexed for MEDLINE]
20.

Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone.

Lai YC, Chiou CC, Chen CH, Huang MC.

J Clin Psychopharmacol. 2007 Oct;27(5):523-4. No abstract available.

PMID:
17873693
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk